170 related articles for article (PubMed ID: 26825905)
21. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.
Goncharuk VN; del-Rosario A; Kren L; Anwar S; Sheehan CE; Carlson JA; Ross JS
Ann Diagn Pathol; 2004 Feb; 8(1):6-16. PubMed ID: 15129904
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of nm23 gene product expression in patients with colorectal carcinoma treated with radical intent.
Soliani P; Ziegler S; Romani A; Corcione L; Campanini N; Dell'Abate P; Del Rio P; Sianesi M
Oncol Rep; 2004 Jun; 11(6):1193-200. PubMed ID: 15138555
[TBL] [Abstract][Full Text] [Related]
23. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
Du P; Xu B; Zhang D; Shao Y; Zheng X; Li X; Xiong Y; Wu C; Jiang J
Oncotarget; 2017 Jan; 8(1):954-966. PubMed ID: 27888614
[TBL] [Abstract][Full Text] [Related]
24. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of NM23 in patients with gastric cancer: A systematic review and meta-analysis.
Wang QH; Han W; Chen MB; Bao J; Wang BF
J Cancer Res Ther; 2018 Sep; 14(Supplement):S556-S564. PubMed ID: 30249868
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of nm23 protein assessed by color video image analysis in metastatic colorectal cancer: correlation with reduced patient survival.
Berney CR; Yang JL; Fisher RJ; Russell PJ; Crowe PJ
World J Surg; 1998 May; 22(5):484-90. PubMed ID: 9564293
[TBL] [Abstract][Full Text] [Related]
27. Correlates of urokinase-type plasminogen activator in colorectal cancer: positive relationship with nm23 and c-erbB-2 protein expression.
Berney CR; Yang J; Fisher RJ; Russell PJ; Crowe PJ
Oncol Res; 1998; 10(1):47-54. PubMed ID: 9613457
[TBL] [Abstract][Full Text] [Related]
28. The role of nm23 gene in colorectal carcinogenesis.
Tripković A; Tripković I; Tomić S; Kovacić A; Grandić L; Capkun V
Acta Clin Croat; 2012 Mar; 51(1):43-9. PubMed ID: 22920000
[TBL] [Abstract][Full Text] [Related]
29. [Expression and clinical significance of vascular endothelial growth factor-C and nm23-H1 in stage II and III colorectal carcinomas].
Geng QQ; Li Y; Tang CH; Li EX; Wu YY; Zhang GJ
Zhonghua Zhong Liu Za Zhi; 2013 Jun; 35(6):439-44. PubMed ID: 24119904
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effect of upregulated DR-nm23 expression on invasion and metastasis in colorectal cancer.
Qu L; Liang L; Su J; Yang Z
Eur J Cancer Prev; 2013 Nov; 22(6):512-22. PubMed ID: 23765094
[TBL] [Abstract][Full Text] [Related]
31. [Expression and clinical significance of nm23-H1, Fas and FasL in colorectal carcinoma tissues].
Lin MH; Yao YH; Yu JH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):503-5. PubMed ID: 16078572
[TBL] [Abstract][Full Text] [Related]
32. β-catenin overexpression in the nucleus predicts progress disease and unfavourable survival in colorectal cancer: a meta-analysis.
Chen Z; He X; Jia M; Liu Y; Qu D; Wu D; Wu P; Ni C; Zhang Z; Ye J; Xu J; Huang J
PLoS One; 2013; 8(5):e63854. PubMed ID: 23717499
[TBL] [Abstract][Full Text] [Related]
33. Prognostic and clinicopathological significance of nm23-H1 expression in non-small cell lung cancer: A meta-analysis.
Li D; Li W; Tian C; Pang Y; Xu L; Wang Y; Xu X
Medicine (Baltimore); 2022 Sep; 101(39):e30815. PubMed ID: 36181032
[TBL] [Abstract][Full Text] [Related]
34. Expression of nm23-H1 in colorectal cancer: no association with metastases, histological stage, or survival.
Tabuchi Y; Nakamura T; Kuniyasu T; Ohno M; Nakae S
Surg Today; 1999; 29(2):116-20. PubMed ID: 10030735
[TBL] [Abstract][Full Text] [Related]
35. CD44v6 and Nm23-H1 protein expression related to clinico pathological parameters in colorectal cancer.
Messinetti S; Giacomelli L; Fabrizio G; Giarnieri E; Gabatel R; Manno A; Feroci D; Guerriero G; Masci E; Vecchione A
Ann Ital Chir; 2003; 74(1):45-51. PubMed ID: 12870281
[TBL] [Abstract][Full Text] [Related]
36. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological and prognostic implications of polo-like kinase 1 expression in colorectal cancer: A systematic review and meta-analysis.
Ran Z; Chen W; Shang J; Li X; Nie Z; Yang J; Li N
Gene; 2019 Dec; 721():144097. PubMed ID: 31493507
[TBL] [Abstract][Full Text] [Related]
38. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer.
Brenner AS; Thebo JS; Senagore AJ; Duepree HJ; Gramlich T; Ormsby A; Lavery IC; Fazio VW
Am Surg; 2003 Mar; 69(3):203-8; discussion 208. PubMed ID: 12678475
[TBL] [Abstract][Full Text] [Related]
39. Reduced expression of nm23 protein is associated with advanced tumor stage and distant metastases in human colorectal carcinomas.
Ayhan A; Yasui W; Yokozaki H; Kitadai Y; Tahara E
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 63(4):213-8. PubMed ID: 8099459
[TBL] [Abstract][Full Text] [Related]
40. NM23-H1 immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas.
Cheah PY; Cao X; Eu KW; Seow-Choen F
Br J Cancer; 1998 Apr; 77(7):1164-8. PubMed ID: 9569056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
